Orexo and Sobi agree to advance feasibility study with AmorphOX

Orexo Sweden

Orexo and Sobi advance collaboration after successful exploratory feasibility study with the company´s world-class drug delivery platform, AmorphOX®The feasibility study confirmed that the biomolecule retained its activity after formulation with AmorphOXOrexo has patent applications for AmorphOX formulations relating to biomolecules.View original content:https://www.prnewswire.co.uk/news-releases/orexo-and-sobi-agree-to-advance-feasibility-study-with-amorphox-302059365.html